BLT2 expression improves skin integrity and protects from alterations caused by hyperglycemia in type 2 diabetes

References

• World Health Statistics, WHO. 2015. [accessed 2016 Oct 3]. www.who.int/gho/publications/world_health_statistics/2015/en/
   Google Scholar
• Paneni F, Costantino S, Cosentino F. Molecular mechanism of vascular dysfunction and cardiovascular biomarkers in type 2 diabetes. Cardiovasc Diagn Ther 2014; 4(4):324-32; PMID:25276618
   PubMedGoogle Scholar
• Fonseca VA. Defining and characterizing the progression of type 2 diabetes. Diabetes Care 2009; 32(Suppl 2):S151-6; PMID:19875543; https://doi.org/10.2337/dc09-S301
   PubMed Web of Science ®Google Scholar
• Muller IS, de Grauw WJ, van Gerwen WH, Bartelink ML, van Den Hoogen HJ, Rutten GE. Foot ulceration and lower limb amputation in type 2 diabetic patients in dutch primary health care. Diabetes Care 2002; 25(3):570-4; PMID:11874949; https://doi.org/10.2337/diacare.25.3.570
   PubMed Web of Science ®Google Scholar
• Kamohara M, Takasaki J, Matsumoto M, Saito T, Ohishi T, Ishii H, Furuichi K. Molecular cloning and characterization of another leukotriene B4 receptor. J Biol Chem 2000; 275(35):27000-4; PMID:10889186
   PubMed Web of Science ®Google Scholar
• Yokomizo T, Kato K, Hagiya H, Izumi T, Shimizu T. Hydroxyeicosanoids bind to and activate the low affinity leukotriene B4 receptor, BLT2. J Biol Chem 2001; 276(15):12454-9; PMID:11278893; https://doi.org/10.1074/jbc.M011361200
   PubMed Web of Science ®Google Scholar
• Liu M, Saeki K, Matsunobu T, Okuno T, Koga T, Sugimoto Y, Yokoyama C, Nakamizo S, Kabashima K, Narumiya S, et al. 12-Hydroxyheptadecatrienoic acid promotes epidermal wound healing by accelerating keratinocyte migration via the BLT2 receptor. J Exp Med 2014; 211(6):1063-78; PMID:24821912; https://doi.org/10.1084/jem.20132063
   PubMed Web of Science ®Google Scholar
• Iizuka Y, Yokomizo T, Terawaki K, Komine M, Tamaki K, Shimizu T. Characterization of a mouse second leukotriene B4 receptor, mBLT2: BLT2-dependent ERK activation and cell migration of primary mouse keratinocytes. J Biol Chem 2005; 280(26):24816-23; PMID:15866883; https://doi.org/10.1074/jbc.M413257200
   PubMed Web of Science ®Google Scholar
• Yoo MH, Song H, Woo CH, Kim H, Kim JH. Role of the BLT2, a leukotriene B4 receptor, in Ras transformation. Oncogene 2004; 23(57):9259-68; PMID:15489890
   PubMed Web of Science ®Google Scholar
• Hennig R, Osman T, Esposito I, Giese N, Rao SM, Ding XZ, Tong WG, Büchler MW, Yokomizo T, Friess H, et al. BLT2 is expressed in PanINs, IPMNs, pancreatic cancer and stimulates tumour cell proliferation. Br J Cancer 2008; 99(7):1064-73; PMID:18781173; https://doi.org/10.1038/sj.bjc.6604655
   PubMed Web of Science ®Google Scholar
• Shao WH, Del Prete A, Bock CB, Haribabu B. Targeted disruption of leukotriene B4 receptors BLT1 and BLT2: a critical role for BLT1 in collagen-induced arthritis in mice. J Immunol 2006; 176(10):6254-61; PMID:16670336; https://doi.org/10.4049/jimmunol.176.10.6254
   PubMed Web of Science ®Google Scholar
• Cho KJ, Seo JM, Shin Y, Yoo MH, Park CS, Lee SH, Chang YS, Cho SH, Kim JH. Blockade of airway inflammation and hyperresponsiveness by inhibition of BLT2, a low-affinity leukotriene B4 receptor. Am J Respir Cell Mol Biol 2010; 42(3):294-303; PMID:19448154; https://doi.org/10.1165/rcmb.2008-0445OC
   PubMed Web of Science ®Google Scholar
• Matsunaga Y, Fukuyama S, Okuno T, Sasaki F, Matsunobu T, Asai Y, Matsumoto K, Saeki K, Oike M, Sadamura Y, et al. Leukotriene B4 receptor BLT2 negatively regulates allergic airway eosinophilia. FASEB J 2013; 27(8):3306-14; PMID:23603839; https://doi.org/10.1096/fj.12-217000
   PubMed Web of Science ®Google Scholar
• Iizuka Y, Okuno T, Saeki K, Uozaki H, Okada S, Misaka T, Sato T, Toh H, Fukayama M, Takeda N, et al. Protective role of the leukotriene B4 receptor BLT2 in murine inflammatory colitis. FASEB J 2010; 24(12):4678-90; PMID:20667973; https://doi.org/10.1096/fj.10-165050
   PubMed Web of Science ®Google Scholar
• Ishii Y, Saeki K, Liu M, Sasaki F, Koga T, Kitajima K, Meno C, Okuno T, Yokomizo T. Leukotriene B4 receptor type 2 (BLT2) enhances skin barrier function by regulating tight junction proteins. FASEB J 2016; 30(2):933-47; PMID:26527063; https://doi.org/10.1096/fj.15-279653
   PubMed Web of Science ®Google Scholar
• Chiba T, Nakahara T, Hashimoto-Hachiya A, Yokomizo T, Uchi H, Furue M. The leukotriene B4 receptor BLT2 protects barrier function via actin polymerization with phosphorylation of myosin phosphatase target subunit 1 in human keratinocytes. Exp Dermatol 2016; 25(7):532-6; PMID:26896822; https://doi.org/10.1111/exd.12976
   PubMed Web of Science ®Google Scholar
• Luo L, Tanaka R, Kanazawa S, Lu F, Hayashi A, Yokomizo T, Mizuno H. A synthetic leukotriene B4 receptor type 2 agonist accelerates the cutaneous wound healing process in diabetic rats by indirect stimulation of fibroblasts and direct stimulation of keratinocytes. J Diabetes Complications 2016; S1056-8727(16):30541-4
   Google Scholar
• Wikramanayake TC, Stojadinovic O, Tomic-Canic M. Epidermal Differentiation in Barrier Maintenance and Wound Healing. Adv Wound Care (New Rochelle) 2014; 3(3):272-280; PMID:24669361; https://doi.org/10.1089/wound.2013.0503
   PubMedGoogle Scholar
• Kabashima K, Murata T, Tanaka H, Matsuoka T, Sakata D, Yoshida N, Katagiri K, Kinashi T, Tanaka T, Miyasaka M, et al. Thromboxane A2 modulates interaction of dendritic cells and T cells and regulates acquired immunity. Nat Immunol 2003; 4(7):694-701; PMID:12778172; https://doi.org/10.1038/ni943
   PubMed Web of Science ®Google Scholar
• Terawaki K, Yokomizo T, Nagase T, Toda A, Taniguchi M, Hashizume K, Yagi T, Shimizu T. Absence of leukotriene B4 receptor 1 confers resistance to airway hyperresponsiveness and Th2-type immune responses. J Immunol 2005; 175(7):4217-25; PMID:16177061; https://doi.org/10.4049/jimmunol.175.7.4217
   PubMed Web of Science ®Google Scholar
• Matsunobu T, Okuno T, Yokoyama C, Yokomizo T. Thromboxane A synthase-independent production of 12-hydroxyheptadecatrienoic acid, a BLT2 ligand. J Lipid Res 2013; 54(11):2979-87; PMID:24009185; https://doi.org/10.1194/jlr.M037754
   PubMed Web of Science ®Google Scholar
• Sasaki F, Okuno T, Saeki K, Min L, Onohara N, Kato H, Shimizu T, Yokomizo T. A high-affinity monoclonal antibody against the FLAG tag useful for G-protein-coupled receptor study. Anal Biochem 2012; 425(2):157-65; PMID:22465329; https://doi.org/10.1016/j.ab.2012.03.014
   PubMed Web of Science ®Google Scholar
• Kuo IH, Carpenter-Mendini A, Yoshida T, McGirt LY, Ivanov AI, Barnes KC, Gallo RL, Borkowski AW, Yamasaki K, Leung DY, et al. Activation of epidermal toll-like receptor 2 enhances tight junction function: implications for atopic dermatitis and skin barrier repair. J Invest Dermatol 2013; 133(4):988-98; PMID:23223142; https://doi.org/10.1038/jid.2012.437
   PubMed Web of Science ®Google Scholar
• Winzell MS, Ahrén B. The high-fat diet-fed mouse: a model for studying mechanisms and treatment of impaired glucose tolerance and type 2 diabetes. Diabetes 2004; 53(Suppl 3):S215-9; PMID:15561913; https://doi.org/10.2337/diabetes.53.suppl_3.S215
   PubMed Web of Science ®Google Scholar
• King AJ. The use of animal models in diabetes research. Br J Pharmacol 2012; 166(3):877-94; PMID:22352879; https://doi.org/10.1111/j.1476-5381.2012.01911.x
   PubMed Web of Science ®Google Scholar
• Gilbert ER, Fu Z, Liu D. Development of a nongenetic mouse model of type 2 diabetes. Exp Diabetes Res 2011; 2011:416254; PMID:22164157; https://doi.org/10.1155/2011/416254
   PubMedGoogle Scholar
• Li P, Oh DY, Bandyopadhyay G, Lagakos WS, Talukdar S, Osborn O, Johnson A, Chung H, Mayoral R, Maris M, et al. LTB4 promotes insulin resistance in obese mice by acting on macrophages, hepatocytes and myocytes. Nat Med 2015; 21(3):239-47; PMID:25706874
   PubMed Web of Science ®Google Scholar
• Fouda MM, Abdel-Mohsen AM, Ebaid H, Hassan I, Al-Tamimi J, Abdel-Rahman RM, Metwalli A, Alhazza I, Rady A, El-Faham A, et al. Deficiency of the leukotriene B4 receptor, BLT-1, protects against systemic insulin resistance in diet-induced obesity. Int J Biol Macromol 2016; 89:582-91; PMID:27174907; https://doi.org/10.1016/j.ijbiomac.2016.05.021
   PubMed Web of Science ®Google Scholar
• Desposito D, Chollet C1, Taveau C, Descamps V, Alhenc-Gelas F, Roussel R, Bouby N, Waeckel L. Improvement of skin wound healing in diabetic mice by kinin B2 receptor blockade. Clin Sci (Lond) 2016; 130(1):45-56; PMID:26443866; https://doi.org/10.1042/CS20150295
   PubMed Web of Science ®Google Scholar
• Kämpfer H, Schmidt R, Geisslinger G, Pfeilschifter J, Frank S. Wound inflammation in diabetic ob/ob mice: functional coupling of prostaglandin biosynthesis to cyclooxygenase-1 activity in diabetes-impaired wound healing. Diabetes 2005; 54(5):1543-51; https://doi.org/10.2337/diabetes.54.5.1543
   PubMed Web of Science ®Google Scholar
• Brownlee M. Advanced protein glycosylation in diabetes and aging. Annu Rev Med 1995; 46:223-34; PMID:7598459; https://doi.org/10.1146/annurev.med.46.1.223
   PubMed Web of Science ®Google Scholar
• List EO, Berryman DE, Palmer AJ, Qiu L, Sankaran S, Kohn DT, Kelder B, Okada S, Kopchick JJ. Analysis of mouse skin reveals proteins that are altered in a diet-induced diabetic state: a new method for detection of type 2 diabetes. Proteomics 2007; 7(7):1140-9; PMID:17390296; https://doi.org/10.1002/pmic.200600641
   PubMed Web of Science ®Google Scholar
• Spravchikov N, Sizyakov G, Gartsbein M, Accili D, Tennenbaum T, Wertheimer E. Glucose effects on skin keratinocytes: implications for diabetes skin complications. Diabetes 2001; 50(7):1627-35; PMID:11423485; https://doi.org/10.2337/diabetes.50.7.1627
   PubMed Web of Science ®Google Scholar
• Terashi H, Izumi K, Deveci M, Rhodes LM, Marcelo CL. High glucose inhibits human epidermal keratinocyte proliferation for cellular studies on diabetes mellitus. Int Wound J 2005; 2(4):298-304; PMID:16618316; https://doi.org/10.1111/j.1742-4801.2005.00148.x
   PubMedGoogle Scholar
• Lan CC, Wu CS, Huang SM, Wu IH, Chen GS. High-glucose environment enhanced oxidative stress and increased interleukin-8 secretion from keratinocytes: new insights into impaired diabetic wound healing. Diabetes 2013; 62(7):2530-8; PMID:23423570; https://doi.org/10.2337/db12-1714
   PubMed Web of Science ®Google Scholar
• Reed MJ, Scribner KA. In-vivo and in-vitro models of type 2 diabetes in pharmaceutical drug discovery. Diabetes Obes Metab 1999; 1(2):75-86; PMID:11220515; https://doi.org/10.1046/j.1463-1326.1999.00014.x
   PubMed Web of Science ®Google Scholar
• Salpea KD, Maubaret CG, Kathagen A, Ken-Dror G, Gilroy DW, Humphries SE. The effect of pro-inflammatory conditioning and/or high glucose on telomere shortening of aging fibroblasts. PLoS One 2013; 8(9):e73756; PMID:24086293; https://doi.org/10.1371/journal.pone.0073756
   PubMed Web of Science ®Google Scholar
• Rozlomiy VL, Markov AG. Effect of interleukin-1β on the expression of tight junction proteins in the culture of HaCaT keratinocytes. Bull Exp Biol Med 2010; 149(3):280-3; PMID:21246082; https://doi.org/10.1007/s10517-010-0927-y
   PubMed Web of Science ®Google Scholar
• Tsai WC, Liang FC, Cheng JW, Lin LP, Chang SC, Chen HH, Pang JH. High glucose concentration up-regulates the expression of matrix metalloproteinase-9 and -13 in tendon cells. BMC Musculoskelet Disord 2013; 14:255; PMID:23981230; https://doi.org/10.1186/1471-2474-14-255
   PubMed Web of Science ®Google Scholar
• Lan CC, Liu IH, Fang AH, Wen CH, Wu CS. Hyperglycaemic conditions decrease cultured keratinocyte mobility: implications for impaired wound healing in patients with diabetes. Br J Dermatol 2008; 159(5):1103-15; PMID:18717678
   PubMed Web of Science ®Google Scholar
• Pan F, Guo R, Cheng W, Chai L, Wang W, Cao C, Li S. High glucose inhibits ClC-2 chloride channels and attenuates cell migration of rat keratinocytes. Drug Des Devel Ther 2015; 9:4779-91; PMID:26355894
   PubMedGoogle Scholar
• Pavan B, Capuzzo A2, Forlani G. High glucose-induced barrier impairment of human retinal pigment epithelium is ameliorated by treatment with Goji berry extracts through modulation of cAMP levels. Exp Eye Res 2014; 120:50-4; PMID:24345371; https://doi.org/10.1016/j.exer.2013.12.006
   PubMed Web of Science ®Google Scholar
• Qing Q, Zhang S, Chen Y, Li R, Mao H, Chen Q. High glucose-induced intestinal epithelial barrier damage is aggravated by syndecan-1 destruction and heparanase overexpression. J Cell Mol Med 2015; 19(6):1366-74; PMID:25702768; https://doi.org/10.1111/jcmm.12523
   PubMed Web of Science ®Google Scholar
• Breton J, Woolf D, Young P, Chabot-Fletcher M. Human keratinocytes lack the components to produce leukotriene B4. J Invest Dermatol 1996; 106(1):162-7; PMID:8592068; https://doi.org/10.1111/1523-1747.ep12329890
   PubMed Web of Science ®Google Scholar
• Allombert-Blaise C, Tamiji S, Mortier L, Fauvel H, Tual M, Delaporte E, Piette F, DeLassale EM, Formstecher P, Marchetti P, et al. Terminal differentiation of human epidermal keratinocytes involves mitochondria- and caspase-dependent cell death pathway. Cell Death Differ 2003; 10(7):850-2; PMID:12815468; https://doi.org/10.1038/sj.cdd.4401245
   PubMed Web of Science ®Google Scholar
• Wikramanayake TC, Stojadinovic O, Tomic-Canic M. Epidermal differentiation in barrier maintenance and wound healing. Adv Wound Care (New Rochelle) 2014; 3(3):272-280; PMID:24669361; https://doi.org/10.1089/wound.2013.0503
   PubMedGoogle Scholar
• Thyssen JP, Linneberg A, Carlsen BC, Johansen JD, Engkilde K, Hansen T, Pociot F, Pedersen O, Meldgaard M, Szecsi PB, et al. A possible association between a dysfunctional skin barrier (filaggrin null-mutation status) and diabetes: a cross-sectional study. BMJ Open 2011; 1(1):e000062; PMID:22021744; https://doi.org/10.1136/bmjopen-2011-000062
   PubMed Web of Science ®Google Scholar
• Nakahara T, Mitoma C, Hashimoto-Hachiya A, Takahara M, Tsuji G, Uchi H, Yan X, Hachisuka J, Chiba T, Esaki H, et al. Antioxidant Opuntia ficus-indica Extract Activates AHR-\NRF2 Signaling and Upregulates Filaggrin and Loricrin Expression in Human Keratinocytes. J Med Food 2015; 18(10):1143-9; PMID:26061570; https://doi.org/10.1089/jmf.2014.3396
   PubMed Web of Science ®Google Scholar
• Wertheimer E, Spravchikov N, Trebicz M, Gartsbein M, Accili D, Avinoah I, Nofeh-Moses S, Sizyakov G, Tennenbaum T. The regulation of skin proliferation and differentiation in the IR null mouse: implications for skin complications of diabetes. Endocrinology 2001; 142(3):1234-41; PMID:11181540
   PubMed Web of Science ®Google Scholar
• Presland RB, Kuechle MK, Lewis SP, Fleckman P, Dale BA. Regulated expression of human filaggrin in keratinocytes results in cytoskeletal disruption, loss of cell-cell adhesion, and cell cycle arrest. Exp Cell Res 2001; 270(2):199-213; PMID:11640884; https://doi.org/10.1006/excr.2001.5348
   PubMed Web of Science ®Google Scholar
• Leguina-Ruzzi A, Pereira J, Pereira-Flores K, Valderas JP, Mezzano D, Velarde V, Sáez CG. Increased RhoA/Rho-Kinase Activity and Markers of Endothelial Dysfunction in Young Adult Subjects with Metabolic Syndrome. Metab Syndr Relat Disord 2015; 13(9):373-80; PMID:26512756; https://doi.org/10.1089/met.2015.0061
   PubMed Web of Science ®Google Scholar